ACR 2026: DAPIROLIZUMAB PEGOL ASSOCIATED WITH GREATER TREATMENT RESPONSE RATES VERSUS PLACEBO IN SLE USING NOVEL TREATMENT RESPONSE MEASURE

Reuters · 2d ago

Please log in to view news